The WHO are amongst those aiding the Government of Zimbabwe to begin an oral cholera vaccination campaign yesterday, in efforts to immunize 1.4 million people living in high-risk regions in Harare, the capital of Zimbabwe.
The first population-level evidence has proved the rotavirus vaccination saves lives in low-income settings.
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
New study finds that the oral rotavirus vaccine response could be influenced by changes in the human microbiota.
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
Experimental HIV-1 vaccine regimen is safe and elicits a robust immune response according to results of a Phase I/IIa clinical trial.
In this interview we take a look at cholera outbreak situations and the strategies required to tackle them as we talk to Martin Mengel following his presentation at ECCMID.
A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
Through a process of elimination, researchers have identified membrane surface proteins on T. pallaidum, which can be targeted by immune antibodies.
